The IMPaCT trial: Individualised Molecular Pancreatic Cancer Therapy. A pilot, randomized, open label Phase II trial assessing first line treatment with gemcitabine or personalized treatment based on tumour molecular signature in patients with metastatic pancreatic cancer. Conference Proceedings uri icon

Overview

Authors

  • Authorship

    • CHANTRILL L
    • LEE C
    • YIP S
    • MILLER D
    • SEBASTIAN L
    • ASGHARI R
    • HARVEY S
    • PAVIAKIS N
    • MUKHEDKAR S
    • GRIMISON P
    • MILLER D
    • JOHNS A
    • PEARSON J
    • WADDELL N
    • PROF Sean Grimmond
    • SIMES J
    • BIANKIN A
    • NAGRIAL A
    • CHIN V
    • CHOU A
    • PINESE M
    • MEAD S
    • GEBSKI V
    • SJOGUIST K

Published in

  • Molecular Cancer Therapeutics

Time

Date/time value

  • 2013

Identity

Digital Object Identifier (DOI)

  • 10.1158/1535-7163.TARG-13-A75

Additional Document Info

Parent Title

  • MOLECULAR CANCER THERAPEUTICS

Volume

  • 12

Issue

  • 11

Publisher

  • American Association for Cancer Research